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Background: In response to COVID-19, there has been increasing momentum in telehealth development and delivery. To
assess the anticipated exponential growth in telehealth, it is important to accurately capture how telehealth has been used in
specific mental health fields prior to the pandemic.
Objective: This systematic review aimed to highlight how telehealth has been used with clinical samples in the neurodevelopmental
field, including patients with neurodevelopmental disorders (NDDs), their families, and health care professionals. To identify
which technologies show the greatest potential for implementation into health services, we evaluated technologies for effectiveness,
economic impact, and readiness for clinical adoption.
Methods: A systematic search of literature was undertaken in April 2018 and updated until December 2019, by using the
Medline, Web of Science, Scopus, CINAHL Plus, EMBASE, and PsycInfo databases. Extracted data included the type of
technology, how the technology was used (ie, assessment, treatment, and monitoring), participant characteristics, reported outcomes
and authors’ views on clinical effectiveness, user impact (ie, feasibility and acceptability), economic impact, and readiness for
clinic adoption. A quality review of the research was performed in accordance with the Oxford Centre for Evidence-Based
Medicine Levels of Evidence.
Results: A total of 42 studies met the inclusion criteria. These studies included participants and family members with autism
spectrum disorders (21/42, 50%), attention deficit hyperactivity disorders (8/42, 19%), attention deficit hyperactivity or autism
spectrum disorders (3/42, 7%), communication disorders (7/42, 17%), and tic disorders (2/42, 5%). The focus of most studies
(33/42, 79%) was on treatment, rather than assessment (4/42, 10%) or monitoring (5/42, 12%). Telehealth services demonstrated
promise for being clinically effective, predominantly in relation to diagnosing and monitoring NDDs. In terms of NDD treatment,
telehealth services were usually equivalent to control groups. There was some evidence of positive user and economic impacts,
including increased service delivery efficiency (eg, increased treatment availability and decreased waiting times). However, these
factors were not widely recorded across the studies. Telehealth was demonstrated to be cost-effective in the few studies that
considered cost-effectiveness. Study quality varied, as many studies had small sample sizes and inadequate control groups. Of
the 42 studies, only 11 (26%) were randomized controlled trials, 12 (29%) were case studies or case series, 6 (14%) were qualitative
studies, and 5 (12%) were noncomparative trials.
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Conclusions: Telehealth has the potential to increase treatment availability, decrease diagnosis waiting times, and aid in NDD
monitoring. Further research with more robust and adequately powered study designs that consider cost-effectiveness and increased
efficiency is needed. This systematic review highlights the extent of telehealth technology use prior to the COVID-19 pandemic
and the movement for investing in remote access to treatments.
Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42018091156;
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018091156
(J Med Internet Res 2021;23(1):e22619) doi: 10.2196/22619
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Introduction
Background
Neurodevelopmental disorders (NDDs) are lifelong disorders
that typically develop during the early stages of child
development and have a high frequency of co-occurrence [1,2].
In this systematic review, NDDs are defined in accordance with
the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition criteria [3], and include autism spectrum disorder (ASD),
attention deficit hyperactivity disorder (ADHD), intellectual
disability, communication disorders, specific learning disorder,
motor disorders, stereotypical movement disorder, and tic
disorders. Young people with NDDs have been identified as
particularly vulnerable to the mental health impacts of
COVID-19, due to changes in support and routine and increased
isolation and loneliness [4,5].
Prior to the COVID-19 pandemic, telehealth interventions were
attracting interest as effective options for improving mental
health provision in overstretched health services. The COVID-19
pandemic has increased the demand for effective mental health
support, and the growing need to offer easy-to-access remote
service availability [4,6,7] has substantially increased telehealth
use [8]. It is therefore essential that we not only identify which
existing telehealth technologies show the greatest efficacy for
use with individuals with NDDs, but also capture the state of
the existing evidence base in order to evaluate the inevitable
growth of this field.
Prior Work
There is no universally agreed upon definition for telehealth
[9]. In this systematic review, we use the term “telehealth” to
encompass telemedicine, telemental health, and telepsychiatry.
In a systematic review of the use of telehealth services for
communication disorders, Molini-Avejonas and colleagues [10]
found that over 85% (88/103) of telehealth studies reported the
advantages that telehealth has over nontelehealth approaches.
For example, Molini-Avejonas and colleagues [10] reported
that telehealth is typically viewed favorably by users and health
care practitioners, as telehealth helps to reduce geographical
barriers and possibly save time during consultations and travel.
However, barriers to telehealth implementation have been
identified. These barriers relate to training, technology issues,
and acceptance by both health care practitioners and patients
[10]. Indeed, a study that explored the views of health care
practitioners (ie, neurologists) toward digital devices in clinical
practice found that while the majority (95%) of the 405
participants used computers regularly at work, less than half
(43.5%) used a tablet [11]. This suggests that one of the barriers
to the uptake of technology may be acceptance from health care
professionals.
Sutherland and colleagues [12] have also updated a systematic
review [13] of telehealth literature on participants with ASD.
During 2010-2016, 14 studies with a total of 284 ASD
participants assessed telehealth services, including assessments,
interventions, functional behavioral analyses, and language
therapy. These studies included a variety of controls, including
comparisons between telehealth and face-to-face sessions (6/14,
43%), online learning with and without telehealth sessions (6/14,
43%), and telehealth services that provided no intervention and
those that provided treatment as usual (2/14, 14%). Although
these studies varied in quality, telehealth services were
comparable to face-to-face services and better than
control/comparison groups in experimental studies. Another
systematic review found that telehealth systems have been used
to deliver education to parents and support the diagnosis and
treatment of ASD [14].
In terms of ADHD, only 1 systematic review has focused on
the use of telehealth. This review found 11 articles, which all
reported data from 3 trials that were conducted in 2007-2017
[15]. The majority (10/11, 91%) of studies used a sample of
children. Telehealth was viewed favorably, as it was well
accepted by health care professionals and users and shown to
provide improved outcomes, such as reduced symptomology
and improved functioning. However, the authors concluded that
further research was necessary to assess the usefulness of
telehealth in health care delivery [15]. This review highlighted
a lack of research on using telehealth to replace usual treatment
rather than augment usual treatment, and a lack of studies that
consider the assessment, diagnosis, and treatment of adults with
ADHD.
Although condition-specific systematic reviews have been
conducted, no single review has assessed the use of telehealth
across people with different NDDs. This is important, given the
prevalence of NDD comorbidities. Many previous reviews have
also been limited to trials. Although trials are important, user
feedback, economic impact, and readiness for clinical adoption
are important for rapidly developing policies for implementing
telehealth services after the COVID-19 pandemic.
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The Goal of This Study
The aim of this systematic review was to highlight how
telehealth has been used, prior to the COVID-19 pandemic,
with clinical samples within the neurodevelopmental field,
including patients with NDD, their families, and health care
professionals. In light of the post-COVID-19 pandemic call for
implementing the rapid adoption of telehealth into clinical
practice [16], this systematic review focused on studies that
reported on the clinical/service effectiveness, economic impact,
and user impact (ie, feasibility/acceptability) of telehealth to
aid in assessment, diagnosis, monitoring, and treatment. This
review serves to identify potentially effective telehealth
technologies for use with patients with NDDs and document
the evidence base prior to the anticipated rapid expansion of
telehealth in the neurodevelopmental field.
Methods
Study Design
This systematic review was part of a larger review [17], which
assessed all technology that has been used for NDDs. The
protocol for our main review was registered with PROSPERO
(CRD42018091156). Given the vast number of obtained papers
that related to telehealth, it was most appropriate to present
these in a stand-alone article. The literature search was
undertaken in accordance with the recommended principles in
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [18].
Search Strategy
A systematic search of literature was undertaken by an
information specialist (EY) using the following databases:
Medline, Web of Science, Scopus, CINAHL Plus, EMBASE,
and PsycInfo. Searches were also performed in the Cochrane
Library, Journal of Medical Internet Research, Institute of
Electrical and Electronics Engineers, and Association for
Computing Machinery Digital Library databases. The search
included all terms that related to NDDs and telehealth, including
controlled vocabulary headings such as “Intellectual Disability,”
“Mentally Disabled Persons,” “Learning disorders,”
“Developmental Disabilities,” “Neurodevelopmental Disorders,”
and “Telemedicine.” Keywords and synonyms that related to
all NDDs, including “ASD,” “ADHD,” “Tic Disorders,”
“Communication and Language Disorders,” “Learning
Disorders,” and “Learning Disabilities,” were also used for the
search. Terms that related to telehealth included keywords, such
as “tele care,” “tele coaching,” “telecomm,” “teleconference,”
“teleconsultation,” “telehealth,” and “telemanagement,” as well
as terms that related to teletherapy, telepractice, and eHealth.
As this study was part of a wider search of all technologies,
additional terms that related to various technologies, such as
mobile apps, video games, virtual reality, and robotics, were
also included. However, the results of the search for these terms
are presented in another study [17]. A copy of the Medline
search strategy is included in Multimedia Appendix 1. Endnote
software (Clarivate) and Microsoft Excel were used to manage
the data. The initial search was restricted to published,
peer-reviewed, academic papers written in English, and was
conducted in March/April 2018 and recently updated in July
2020 to cover the period of January 2014 to December 2019.
The World Health Organization has acknowledged December
2019 as the month that the first case of COVID-19 was officially
recorded [19].
PICOS (population, intervention, comparison, outcome, study
design) guidelines were used to define the inclusion criteria.
With regard to population, we included studies that involved
people with NDDs or parents, carers, or health care professionals
who worked with people with NDDs. With regard to
intervention, we included studies that clinically used telehealth
equipment in the assessment, diagnosis, monitoring, or treatment
of NDDs. No restrictions on comparisons were put in place for
literature. With regard to outcomes, included studies were to
have at least 1 outcome of interest from clinical effectiveness,
economic impact, and user impact. Based on the National
Institute of Clinical Excellence glossary, the following terms
were referred to in the search: (1) “clinical effectiveness,” which
refers to how beneficial telehealth was in terms of assessment,
monitoring, or treatment compared to usual care, a control
group, or another type of care; (2) “economic impact,” which
refers to the evaluation of service delivery efficiencies (eg,
whether an intervention reduces clinician time), as well as any
economic evaluation (eg, cost-effectiveness or costs and benefits
evaluations) of telehealth; and (3) “user impact,” which refers
to the feasibility of using telehealth in terms of technical
feasibility (ie, how simple or difficult it was to use telehealth
services) and the administrative infrastructure (ie, how the
technology fits within an organization). Usability impact also
covered design factors that affect the user experience and users’
acceptability of the technology (ie, users’ willingness to attend
and engage with the technology). With regard to study types,
we excluded systematic reviews and meta-analyses.
Studies on telehealth were restricted to those that used
synchronous (ie, real-time) remote clinical care in relation to
the diagnosis, monitoring, or treatment of an NDD. Although
studies that involved both audio and video communication were
included, studies that provided care via only a telephone were
excluded. Studies were also excluded if they used asynchronous
(ie, nonreal-time) data, including email communications between
patients and health care practitioners, physiological data (eg,
electroencephalogram data) that were remotely interpreted, and
data regarding telehealth services that were delivered solely in
educational/employment settings, such as schools or vocational
training centers. In addition, studies were excluded if they did
not involve an NDD clinical sample or if they focused on
lifestyle interventions (eg, obesity management rather than NDD
treatment).
Data Extraction and Quality Assessment
Titles and abstracts were reviewed for initial screening, and
excluded papers were further independently screened. Two
authors (AZV and CLH) independently reviewed full texts and
extracted data by using an Excel database. Extracted data
included authors and the year of publication; brief summaries
of the study design, including the type of telehealth used and
study methods; how the technology was used (ie, assessment,
treatment, or monitoring); and information on participant
samples, including the number of participants in a sample, health
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condition, gender, population type (ie, parent, clinician, or
children/young people populations), and age (ie, if children
were studied). The relevant outcomes that related to the authors’
views on clinical effectiveness, user impact, economic impact,
and readiness for clinic adoption were also noted. Results were
synthesized in tabulated form (Multimedia Appendix 2).
A quality review of the research was also conducted. Papers
were appraised by 3 authors (CLH, SSH, and BJB) based on
the Oxford Centre for Evidence-Based Medicine Levels of
Evidence. Each paper was rated with a score of 1-5; randomized
controlled trials (RCTs) were typically ranked high (score=1)
and qualitative papers/judgments were typically ranked low
(score=5). Throughout the paper, this score is referred to as a
quality rating (QR) [20]. Disagreements were resolved through
discussion.
Results
The process of identifying and selecting studies is outlined in
a flow diagram (Figure 1), and a summary of the included papers
is presented in Multimedia Appendix 2.
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 flow diagram depicting the study selection process.
Study Characteristics
A total of 42 studies met the inclusion criteria. The greatest
number of studies were conducted on ASD (22/42, 52%) and
ADHD (8/42, 19%). Studies on communication disorders (7/42,
17%), and tic disorders (2/42, 5%) were the least represented.
Additionally, 3 (7%) studies used a sample of participants with
ADHD, ASD, or both. Of the 42 papers, 23 (55%) reported a
wide range of additional diagnoses, such as another coexisting
NDD (10/23, 43%), oppositional defiant disorder (7/23, 30%),
and anxiety (4/23, 17%), and 19 (45%) studies did not report
any comorbidities. Most studies (29/42, 69%) reported data
from children’s parents/carers. Of these 29 studies, 22 (76%)
included children aged <7 years, 3 (10%) included adult
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telehealth service users, and 7 (30%) documented the perspective
of health care professionals. Approximately half (20/42, 48%)
of all papers reported on data from a male or predominantly
male sample. However, in parent/carer studies, the primary
caregiver was more likely to be female. Most studies were
conducted in the United States (27/42, 64%), Australasia (7/42,
17%) and Europe (6/42, 14%). Studies typically focused on




Summary of Assessment Papers
We found 4 papers that focused on the assessment of NDDs.
Of these 4 papers, 3 (75%) used telehealth to remotely diagnose
ASD [21-23] and 1 (25%) assessed the objective measurement
of hyperactivity in patients diagnosed with ADHD [24]. All
ASD studies involved parents and children under 6 years of
age. The ADHD study involved children and young people aged
6-16 years. All studies had ≤65 participants (range 17-65;
Multimedia Appendix 2). Of the 4 papers, 3 (75%) had a QR
of 2 [22] or 3 [23,24], and 1 (25%) [21] had the lowest QR of
5.
Clinical Effectiveness
The Wehrmann and Müller [24] pilot non-RCT used webcam
footage to create a video-activity score to measure physical
activity as an objective assessment of hyperactivity in children
with suspected ADHD. The video-activity score did not show
criterion validity with clinicians’ or parents’ hyperactivity
ratings.
The findings from the ASD studies were more favorable. Reese
and colleagues [22], who reported preliminary RCT findings
on which families were assigned to in-clinic or telehealth
evaluations, found that families could be coached to complete
ASD assessment activities with young children via
videoconferencing and clinicians could make accurate diagnoses
remotely. Similarly, Juarez et al [21] reported on 2 studies, of
which 1 compared a telediagnosis to a face-to-face assessment.
This study demonstrated that, compared to gold-standard tools,
remote ASD diagnostic consultations resulted in clinicians
correctly diagnosing 78.9% (15/19) of children. No children
were inaccurately diagnosed with ASD. Stainbrook and
colleagues [23] investigated referrals before and after the
introduction of a telehealth service. They found that
implementing a diagnostic consultation service for ASD, in
partnership with an early intervention service, increased referrals
for diagnostic evaluation and the likelihood of families attending
appointments. Following referral, 56 (89%) of the 63 families
chose to receive further appointments via telehealth services
rather than face-to-face services, and families with complex
problems were the most likely to access clinic services.
User Impact, Feasibility, and Acceptability
In a second qualitative feasibility study, Juarez and colleagues
[21] reported positive user feedback from both health care
professionals and families. Families from rural areas reported
geographical and time barriers to accessing traditional health
care. These barriers were reduced with remote diagnoses,
leading to high levels of satisfaction. Stainbrook and colleagues
[23] found that families were more likely to attend telehealth
appointments. Following referral, 56 (89%) of the 63 families
chose to receive appointments via telehealth services rather than
face-to-face services, and families with complex problems were
the most likely to access clinic services.
Service Delivery Efficiencies and Economic Impact
Stainbrook and colleagues [23] were the only authors to
document service delivery efficiencies. They reported that
implementing a telehealth service reduced the time to diagnosis
by 11-12 months.
Readiness for Clinic Adoption
Despite the effectiveness and positive user impact of telehealth
in the assessment of ASD, the studies all had a small sample
size. Of the 3 ASD papers, 1 (33%) did not report on suitability
for implementation [23] and 2 (67%) stated that further research
is necessary [21,22]. The ADHD assessment paper [24] reported
negative findings and concluded that telehealth assessments for
ADHD were not suitable for implementation. As such, prior to
the COVID-19 pandemic, there were no telehealth technologies
that were reported to be efficacious in assessing NDDs and
suitable for immediate adoption in practice.
Monitoring
Summary of Monitoring Papers
We found 5 articles that reported on a sample of children with
ADHD and their families. All papers were based on the CATTS
(Children’s ADHD Telemental Health Treatment Study) [25].
We found an RCT that assessed the effectiveness of a telehealth
service for children with ADHD, which included
pharmacological treatment monitoring and caregiver behavior
training/psychoeducation. The RCT study compared families
who received augmented treatment as usual, which involved
only 1 telehealth consultation, to families who received 6
telehealth sessions, which were conducted approximately 1
month apart. The papers were generally highly rated (QR=2),
and the main study was an RCT. Secondary papers looked at
caregiver outcomes [26,27] and health care professionals’
decisions on medication changes [28]. The remaining paper
received a low QR (QR=5) because of the qualitative nature of
the report, which focused on caregiver satisfaction and
engagement, and health care professional fidelity [29]. Although
not all studies were directly related to monitoring, they were
collated together to allow the reader to understand that data
were from multiple articles that related to the same trial. We
found 4 studies that were based on the main trial’s dataset, which
included 223 families of children with ADHD aged 5-12 years
and their carers [25]. The remaining study [27] involved a
subsample of 37 participants.
Clinical Effectiveness
Overall, both methods of telehealth delivery resulted in
reductions in ADHD and oppositional defiant disorder behaviors
and improvements in role performance and impairment, with
the telehealth model generally resulting in better outcomes [25]
and better parental mental health [26] than face-to-face models.
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In a feasibility trial of a subsample of families, Tse and
colleagues [27] assessed the outcomes from baseline to 25 weeks
and found similar outcomes for child ADHD behaviors.
However, they also found that parents who used telehealth
services had considerably less improvement in caregiver strain
and empowerment than those who received face-to-face training.
User Impact, Feasibility, and Acceptability
High levels of engagement and satisfaction were reported by
parents [27,29]. Rockhill et al [28] reported that fidelity was
not impacted by telehealth delivery. The authors argued that
telehealth provides added value in terms of increasing
treat-to-target goals and offering support to health care
professionals.
Service Delivery Efficiencies and Economic Impact
Service delivery efficiencies and economic impact were not
reported in any monitoring papers.
Readiness for Clinic Adoption
Myers and colleagues [25] provided clinical guidance regarding
the use of telehealth in treating children with ADHD, and the
results from the RCT were promising. Further research is
recommended in the development of the CATTS trial, including
research that involves the greater use of teachers in interventions
and objective school outcome measures, such as the completion
of homework and behavioral observations, to further validate
the tool. Tse and colleagues [27] concluded that telehealth
delivery was promising in terms of readiness for clinic adoption,
but telehealth for caregivers’ distress needed further study,
including the investigation of the best delivery modality. Future
research on the cost benefits of telehealth models of care for
ADHD was also recommended. These findings indicated
promise in the implementation of technologies for monitoring
ADHD.
Treatment
We found 33 papers that reported on the use of telehealth
technologies to treat NDDs. The majority of the papers focused
on ASD (18/33, 55%). Other reported conditions were ADHD
with or without ASD (5/33, 15%), communication disorders
(7/33, 21%), tic disorders (2/33, 6%) and learning disabilities
(1/33, 3%). Due to the volume of treatment papers, each
condition will be considered in turn.
ASD
Summary of ASD Treatment Papers
In terms of ASD, 1 paper presented a case report of a
16-year-old male with Asperger syndrome, social isolation, and
depression. Clarke [30] reported that communicating via
telehealth allowed a clinician to develop a relationship with a
young person who was later able to attend a clinic in person
and reconnect with his family. The remaining papers (17/18,
94%) focused on some aspect of parent training. Of these 17
papers, 6 (35%) reported on providing telehealth-delivered
functional analysis and communication training to parents
[31-36], and 1 (6%) reported on using telehealth-delivered
functional analysis to train a health care professional [37]. These
studies mainly consisted of case studies or case series (6/7, 86%)
that used a multiple baseline experimental design and had a QR
of 3 [35] or 4 [31,32,34,36,37]. Another paper (1/7, 14%)
reexamined 2 nonresponding participants’ data from an RCT
(QR=4) [33].
We found 4 studies on 4 programs that incorporated self-directed
online learning with remote therapy, support, or coaching
[38-41]. These included studies on ImPACT Online
Communication Training [38,39], which evaluated the feasibility
(QR=4) and clinical efficacy (QR=3) of the ImPACT Online
program in addressing social communication development, and
a noncomparative feasibility study (QR=4) on OASIS ABA
(Online and Applied System for Intervention Skills Applied
Behavior Analysis)–based parent training [40]. Another
program, which involved reciprocal imitation training, was used
in a single-subject multiple-baseline design study (QR=4) [41].
In a noncomparative trial that gathered data from before and
after intervention (QR=4), Little and colleagues [42] studied
occupational-based coaching via telehealth for increasing
positive interactions and everyday routines. This included an
evaluation of acceptability/cost [43] and a linked qualitative
(QR=5) appraisal of parents’ perceptions [44]. The remaining
programs were the Sunny Starts parent training program for
increasing sociocommunicative behavior, which was used in a
case series with multiple baseline experimental data (QR=4)
[45]; the RUBI-PT (Research Unit on Behavioral
Interventions-Parent Training) program, which was developed
by the Research Unit on Behavioral Interventions Autism
Network and targeted behaviors such as aggression and tantrums
in children with ASD; benchmarking, which was used in a trial
that compared the data of new services to data from previously
published clinical trials (QR= 4) to evaluate effectiveness (eg,
reduction in disruptive behavior), feasibility, and acceptability
[46]; and parent coaching with a focus on educating parents
about effective approaches for children with ASD (eg, social
narratives and visual schedules), which was used in a qualitative
paper (QR=5) [47].
Clinical Effectiveness
The majority of the ASD papers reported that treatment was
clinically effective in improving caregiver knowledge, caregiver
competence, and child participation (6/18, 33%) [38-42,45],
increasing communication responses (2/18, 11%) [34,45], and
reducing problem behaviors (5/18, 28%) [31,32,35-37]. We
found 1 (5%) paper [33] that discussed 2 young children with
ASD who underwent functional communication training, but
this was unsuccessful in reducing problem behaviors. The
authors suggested that although not all patients can be treated
via telehealth, if sessions are recorded, watching the recordings
can lead to the identification of the reason why treatment was
not successful. Ingersoll and colleagues [39] noted that both
online self-directed training and therapist-assisted,
parent-mediated telehealth intervention led to improvements in
fidelity, self-efficacy, stress, and parents’ perceptions of their
child, and that families who received therapist coaching and
support gained improved social skills.
User Impact, Feasibility, and Acceptability
High levels of engagement and satisfaction were reported by
parents [40,43,46]. However, difficulties surrounding failing
technology and incomplete personal interaction were also
J Med Internet Res 2021 | vol. 23 | iss. 1 | e22619 | p. 6http://www.jmir.org/2021/1/e22619/
(page number not for citation purposes)
Valentine et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
documented [44,47]. Ingersoll and colleagues [38] found that
parental engagement and satisfaction were similar for both
self-directed and therapist-assisted methods of telehealth
delivery. However, having a therapist increased engagement
and led to higher rates of telehealth service completion. Parents
often engaged with the program (ie, without therapist support)
outside of traditional working hours, which allowed for greater
flexibility than in face-to-face coaching.
In a qualitative study, Ashburner et al [47] explored the
perceived advantages and disadvantages of a follow-up early
intervention service that was delivered via remote technology,
by comparing the service to previous face-to-face services.
Content analysis showed that parents, service providers, and
the ASD specialist perceived remote technologies to be helpful
in upskilling parents/service providers and enabling families to
access support from home. However, all study participants
agreed that remote technology should be used to augment, rather
than replace, face-to-face contact, which is similar to the
findings reported by Little et al [43].
The use of telehealth for training health care professionals was
also shown to be a promising way of providing support to
practitioners in the field, which led to the greater implementation
of target strategies [37].
Service Delivery Efficiencies and Economic Impact
Suess and colleagues [32] reported on telehealth service delivery
efficiencies and argued that in some cases, brief, efficient
telehealth appointments bypasses the need for further in-clinic
support and allows for quicker treatment initiation. Several
authors [40,41,47] suggested that telehealth has the potential to
increase access to ASD services (ie, particularly in remote areas)
and reduce costs, time, and travel. Lingren et al [35] compared
the costs of therapy for caregivers of children with ASD between
different telehealth models, including in-home telehealth,
regional clinic telehealth, and in-home, face-to-face telehealth
models. The costs were lowest for the in-home telehealth model,
but the in-home and in-home, face-to-face telehealth models
were substantially less costly than the costs for face-to-face
in-home therapy. Similarly, in a study that involved a 12-week
telehealth intervention for families with a child with ASD, the
authors reported that the costs for both outpatient and in-home
care models were approximately 2.6 times more expensive than
the costs for telehealth models [43].
ADHD
Summary of ADHD Treatment Papers
We found 5 treatment papers from the ADHD sample that
included patients with ADHD and patients with ASD. The
highest quality paper (ie, a small RCT with a QR of 2) compared
patients who underwent internet-based cognitive behavioral
therapy based on the InFocus program (ie, with/without therapist
support) to those in the waitlist control [48]. The other papers
were of much lower in quality. We found 1 experimental pilot
study (QR=5) that used a nonrandomized pre-post intervention
study design to assess the feasibility and acceptability of a
parenting group training program delivered via telehealth [49].
Additionally, Sehlin and colleagues [50] provided qualitative
data (QR=5) for a study that involved a face-to-face meeting
that was followed by 8 weeks of internet-based chat sessions
for providing coaching and support. Another qualitative paper
(QR=5) conducted implementation interviews with health care
professionals after providing coaching and support at 3 trial
sites in Sweden [51]. The final paper used a multiple descriptive
case design (QR=4) to assess caregiver perspectives in a sample
of 10 caregivers of young people with ADHD or ASD who took
part in an internet-based intervention [52].
Clinical Effectiveness
In general, clinical effectiveness was unclear or not reported
(3/5, 60%) [50-52], and all studies were limited by small sample
sizes (range 7-45). We found 2 group therapy telehealth
programs that showed great promise. A study [48] found that
an internet-based cognitive behavioral therapy telehealth
treatment program, which included weekly online group therapy
sessions for adults with ADHD, was no more clinically effective
than unsupported self-help alone. However, people in both
programs faired better than those in the waiting list controls.
The second group therapy program showed a trend of
improvement in child ADHD symptoms following a group
parenting intervention, but the program was not adequately
powered [49].
User Impact, Feasibility, and Acceptability
Sehlin et al [50] found that although remote coaching was
perceived favorably by participants, difficulties surrounded
failing technology and incomplete personal interaction were
reported. Shah and colleagues [49] also reported that clinicians
experienced difficulties with internet connections and found it
hard to read body language and expressions, as faces were
sometimes out of focus during video appointments. They also
reported that patients experienced disturbances from other family
members, and that the inability to role play during telehealth
appointments was problematic. However, parents were at ease
and relaxed during telehealth appointments.
Gillberg and Wentz [51] assessed professionals’ perceptions on
internet-based support and coaching and the barriers and
facilitators to implementation. Facilitators of positive
perceptions included improved access, equality distribution,
and the delivery/quality of health care services. Reported barriers
included the design of the intervention, technical issues, attitudes
of staff, organizational culture and structure, and work division
and resource allocation.
Service Delivery Efficiencies and Economic Impact
Most studies (4/5, 80%) did not report the economic impact.
However, cost-savings in terms of time and travel were noted
in 1 (20%) study [49].
Other NNDs (ie, Communication Disorders, Tic
Disorders, and Learning Disabilities)
Summary of Other Treatment Papers
Treatment programs for communication disorders (eg, stuttering)
were evaluated in 7 papers. A noncomparative trial (QR=4)
investigated the Camperdown Program, which was used to
reduce stuttering in adolescents [53]. The remaining papers
assessed the Lidcombe program for preschoolers. With regard
to the Lidcombe program, we found 1 RCT (QR=2) that
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compared telehealth care delivery to in-clinic, face-to-face care
delivery [54], and 1 study (QR=2) that involved a quantitative
evaluation of parent satisfaction ratings [55]. We found 1 paper
(QR=4) that involved a noncomparative trial that assessed
reductions in stuttering severity and frequency, as well as
satisfaction with telehealth delivery [56]. The remaining papers
all had the lowest quality rating (QR=5). We found 2 papers
that discussed clinical insights from health care professionals
who were involved in telehealth treatment delivery for patients
with stuttering [57,58]. We also found a descriptive-analytic
study of satisfaction with telehealth treatment for stuttering [59].
Furthermore, we found 2 papers on a pilot open-case series
(QR=4) [60] and an RCT that used a waiting list control for the
assessment and treatment of chronic tic disorders (QR=2) [61].
The final paper (QR=5) provided an account of a telehealth
service that was delivered at a large-scale regional service level
[62].
Clinical Effectiveness
In terms of the Lidcombe program, the Phase I [56] trial
demonstrated the efficacy of remotely delivering the program
to families with a preschool child who stutters. However, the
results of a main parallel, open-plan, noninferiority RCT trial
[54] showed that it was not clear whether webcam treatment
was noninferior to standard treatment in the short term. Carey
and colleagues [53] conducted a Phase II clinical trial that
examined adolescents’ responsiveness to the webcam-delivered
Camperdown program, and found that adolescents experienced
substantially reduced stuttering in terms of both frequency and
severity, although relapse was a problem.
User Impact, Feasibility, and Acceptability
High levels of engagement and satisfaction were reported by
parents/carers [53,60,61]. The use of telehealth to train health
care professionals was shown to be a promising way of
providing support to practitioners in the field [58]. Jahromi and
Ahmadian [59] explored satisfaction in telespeech therapy
among 30 Iranian patients aged ≥14 years. The authors reported
that satisfaction with the therapy was high, but the low internet
speed in the country was a major challenge for half the
participants, as they could not maintain eye contact with the
therapist due to the distorted image transmission. Similarly,
another study reported that difficulties arose with regard to
completing certain aspects of treatment due to limited web
camera viewing ranges and audio/visual difficulties [61].
The feasibility of delivering both the Lidcombe and
Camperdown programs via telehealth methods was documented,
and parents were generally satisfied [53,54,56]. However,
Bridgman and colleagues [57] highlighted that individual
adjustments were required to tailor the treatment process to
families’needs in order to maximize outcomes. Ferdinands and
Bridgman [55] examined parent satisfaction and stuttering
severity at baseline and during the 9-month/18-month follow
up, and found that increased parental satisfaction was generally,
but not always, linked with the severity of stuttering. This
demonstrates the need to provide treatment at the family level
when monitoring children with communication disorders. There
was no considerable difference in parent satisfaction between
clinic and telehealth care delivery.
Ricketts et al [60,61] conducted pilot studies that explored the
feasibility of assessing tic severity over voice over internet
protocol (VoIP), which allows users to make and receive calls
via an internet connection. They compared the feasibility,
acceptability, and efficacy of VoIP-delivered therapy for tic
disorders to those of a waitlist control. They found a decrease
in tic severity that was similar to the decrease identified in the
original Cognitive Behavioral Intervention for Tics trial [63]
and greater than that of the waitlist control [61].
Service Delivery Efficiencies and Economic Impact
Merrill et al [62] provided an overview of Ohio’s Telepsychiatry
Project for Intellectual Disability, which provides specialized
mental health services to rural communities. This paper
documented telehealth from a service delivery perspective.
Although no specific figures were given, the report indicated
that the service improved access to care, reduced emergency
department visits/hospitalizations, and resulted in cost savings,
including reduced travel expenses, medical expenses, and
support costs. Similar cost savings were reported in other studies
[54,59].
Readiness for Clinic Adoption
Of the 33 treatment papers, 5 (15%) deemed telehealth to be
suitable for clinic adoption, either as an adjunct to current
practices or on its own [30,47,50,59,62]. Furthermore, 24 (73%)
papers noted that telehealth required further research before
being implemented into clinical practice. The remaining papers
were unclear/did not report on readiness for clinic adoption.
Prior to the COVID-19 pandemic, the delivery of interventions
via telehealth for parents of children with ASD, young people
and adults who stutter, and adults with intellectual disability
were thought to be suitable for clinic adoption. For young people
who struggle with attending appointments, therapy conducted
via VoIP was recommended. In addition, coaching and support
via a chat program was recommended as an adjunct to usual
treatment for young people and adults with ADHD/ASD.
Discussion
Principal Results
The purpose of this systematic review was to examine the
evidence base for the clinical use of technology within the
neurodevelopmental field prior to the COVID-19 pandemic, to
identify possible telehealth technologies that can be considered
for wide-spread implementation and document the current state
of the evidence base prior to the anticipated rapid development
in this field.
Assessment
Telehealth has been used to assess small samples of people with
ASD, and telehealth shows promise for clinical adoption. In
terms of economic impact, there are potential cost savings and
service efficiencies, but the evidence base is limited. The ADHD
assessment tool is not clinically effective, and there has been
no evidence for the assessment of other NDDs at present.
Monitoring
As identified in a previous review by Spencer and colleagues
[15], all studies that used telehealth for monitoring were for
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monitoring ADHD, and all studies were from the same trial (ie,
the CATTS [25]), which had promising results for acceptability
and effectiveness. Telehealth monitoring seems to be an
approach that should be considered for clinic adoption.
Treatment
Telehealth has been used to treat a range of NDDs. However,
the majority of conditions fall under ASD, and treatment has
mainly focused on parent training interventions. These
interventions have shown some evidence of clinical efficacy,
such as improving caregiver knowledge, competence, and child
participation, and reducing problem behaviors. Even when
telehealth is not clinically effective, the recording of sessions
can help health care professionals identify why the treatment
did not work [33]. Treatments for communication disorders
have also focused on parent intervention programs, which have
shown some evidence of clinical efficacy and no difference in
parent satisfaction between remote delivery and face-to-face
delivery. Despite the fact that previous literature has suggested
that the evidence for using telehealth to manage communication
disorders is substantial [10], our review did not reveal a large
number of papers that involved communication disorders, as
more papers focused on ASD. Furthermore, our findings on
effectiveness were mixed; the lack of an adequate control group
was a limiting factor in several studies [53].
We found little evidence for the delivery of parenting
interventions for ADHD. However, it is possible that the search
terms used in this review limited access to such papers.
Telehealth services for young people and adult service users
tended to focus on the remote delivery of coaching, support,
and therapy. The 1 case study of a young person with ASD who
received online therapy had a promising outcome. People with
ASD may particularly benefit from using technology to
overcome communication difficulties, as this involves fewer
social pressures than face-to-face therapy [64].
Cognitive-behavioral strategies have been used for both ADHD
and tic disorders, and mixed clinical efficacies have been
reported. There is a larger body of evidence for using behavioral
and cognitive-behavioral treatments for tic disorders than
evidence for using such treatments for ADHD, but further
research is necessary for both disorders. There was limited
evidence for using telehealth as a means of providing training
to health care professionals. However, barriers to this approach,
including the design of the intervention, technical issues,
attitudes of staff, organizational culture and structure, and work
division and resource allocation, were widely reported.
In summary, there is a much larger body of evidence for the
efficacy of providing remotely delivered interventions to parents
and children than evidence for providing such interventions to
young people and adult service users. There is also a small body
of evidence for using telehealth to train health care professionals.
Generally, the user impact for all participants was positive.
There was very little research on economic impact. Overall, the
evidence base is of variable quality.
Key Implementation Issues
This systematic review highlighted key implementation issues
for using telehealth services. The number of telehealth
technologies that are ready to be implemented in practice is
limited, as most studies stated that further research is necessary
before such technologies are acceptable for clinical adoption.
Service providers should consider both service users’ opinions
on such technology and the evidence base when choosing
whether to implement telehealth technology into clinical
practice. If families view telehealth technology as an adjunct
to usual treatment, cost savings may not be achieved.
The telehealth delivery of treatments may have benefits. In some
studies, allowing users to access treatment at convenient times
and providing personalized treatment led to greater treatment
engagement and completion. Families were more at ease and
relaxed when participating in telehealth treatment. The need to
personalize treatment to individuals and families was apparent
across several studies. This is particularly important, as
disruptions by other family members can occur. There is limited
evidence for service delivery efficiencies. Implementation
difficulties included failing technology, audio and visual
problems, and difficulties in making eye contact. These were
particularly problematic in countries with low internet speeds.
In line with previous reviews, several studies have reported that
health care professionals found reading body language and facial
expressions difficult due to distorted images [10,65].
Directions for Future Research
This systematic review reveals that there is a lack of research
that assesses the use of telehealth in aiding the diagnosis of a
wide range of NDDs, and that the current focus is on autism.
In general, cost-effectiveness and possible service efficiencies
are underinvestigated, but they are an important consideration
for real-world implementation. Future research should focus on
developing guidelines and blueprints for how to best integrate
telehealth care into clinical practice [66].
Limitations
The limitations of this study must be taken into account when
interpreting the findings. As the search yielded a much greater
number of papers than anticipated, the search was limited to
the previous 5 years. This was a deviation from the initial
protocol. However, it can be argued that this method allows for
a more effective analysis of current technology and precludes
the inclusion of outdated technology. Furthermore, limiting the
search to published academic papers may have exacerbated the
risk of bias, as authors were not contacted for unpublished work
due to the volume of published papers obtained. This is a
limitation of our study, and further reviews should explore
unpublished data, especially data from conference papers, as
these provided a vast amount of possibly relevant data. However,
conference papers were excluded from this systematic review
due to time constraints.
The majority of studies were conducted in high-income
countries, thereby limiting the generalizability of our findings.
It is likely that there would be intercountry variations in barriers
to implementing new technology into existing health care
systems. Although these barriers are typically considered outside
the remit of standard reporting for trials, an understanding of
these barriers is important if these technologies are to be
routinely implemented.
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The majority of data were of mid- to low-quality, and our
findings should be interpreted with caution. This was generally
because of small sample sizes and the high number of
qualitative/reflexive study designs. However, RCTs are
time-consuming and do not always lend themselves to real-world
evaluations.
Conclusions
Our literature search highlighted that, prior to the COVID-19
pandemic, there was promising evidence for the use of telehealth
in clinical practice, in relation to NDDs. Telehealth technologies
were more frequently used to support the treatment and
monitoring of NDDs; there was less evidence for their use in
supporting the assessment of NDDs. The main focus of
telehealth in the neurodevelopmental field was on ASD and
ADHD, which are two of the most commonly occurring NDDs.
There was evidence of good clinical outcomes and cost savings
for health care providers. However, further research is required
to substantiate this evidence. With the growing need to provide
easy access to remotely delivered clinical support for enabling
the wide-spread reach of health care and reducing the risk of
spreading infectious diseases, it is essential that real-world
evaluations for implementation and cost-effectiveness are
conducted.
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